Access to drugs: the case of Abbott in Thailand.
Cawthorne
Paul
P
Ford
Nathan
N
Wilson
David
D
Kijtiwatchakul
Kannikar
K
Purahong
Virat
V
Tianudom
Nimit
N
Nacapew
Supatra
S
D017277:Drug Approval / Q000331:legislation & jurisprudence; D004338:Drug Combinations; D004345:Drug Industry / Q000191:economics / Q000331:legislation & jurisprudence*; D004335:Drug and Narcotic Control / Q000331:legislation & jurisprudence*; D017320:HIV Protease Inhibitors / Q000191:economics / Q000600:supply & distribution; D006297:Health Services Accessibility / Q000331:legislation & jurisprudence*; D006801:Humans; D061466:Lopinavir; D010330:Patents as Topic / Q000331:legislation & jurisprudence*; D011744:Pyrimidinones / Q000191:economics / Q000600:supply & distribution*; D019438:Ritonavir / Q000191:economics / Q000600:supply & distribution*; D013785:Thailand
D004338:Drug Combinations; D017320:HIV Protease Inhibitors; D011744:Pyrimidinones; D061466:Lopinavir; D019438:Ritonavir